I would be more inclined to agree with your confirmatory
I would be more inclined to agree with your confirmatory trial but for the statements from Cyrus that the key opinion leaders were evaluating what population of patients LL might best treat going forward given the changed drug landscape. I took that to mean that they were not looking at that HTE/MDR patient pool that we treated previously. Rather, they were looking outside that box for a different patient pool.
The FDA asking for a cleaned up risk benefit analysis definitely leans in the favor of your hypothesis. But then asking for the go forward for a completely new trial protocol indicates starting a new trial to me.
And the other thing of note is that Cyrus said they had, I can't remember exactly, but something like five trial protocols mostly complete. And that if the key opinion leaders agreed that one of those patient pools was the most fruitful, then CYDY could quickly complete one of those five trial protocols. But it obviously took substantially longer than we were led to expect. That indicates to me that they key opinion leaders thought of a patient pool that was outside of those original five.
3
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Transforming Lighting in Retail Spaces Folks, let's talk lighting. Not the humdrum switch-you-on kind, but something much snazzier, more customized, and downright interactive. I'm talking about Linkind's latest brainchild—the Smart Light Stick. Launched amidst the neon rush of tm:rw in New York City, this gizmo isn't just another bulb in the home improvement aisle. It's...
Continue Reading
What's Driving Airswift's Latest Expansion? Airswift just dropped a bombshell by snapping up key businesses from New Tech Global (NTG), marking a serious power move in the U.S. energy sector. Now, what does this actually mean for investors? In blunt terms: they're muscling up their contractor base by a meaty 30%. That's no small feat. It's a calculated step to ace the...
Continue Reading
American Savings Bank Lands with a Bang on NYSE Who would have thought American Savings Bank's (NYSE: ASBH) entry onto the stock market would start with such gusto? It's not every day you see a debut that impressive, with shares soaring 6.25% right out of the gate. Guess it's safe to say the folks over at ASBH did something right in the lead-up to their NYSE launch. CEO...
Continue Reading
A Veteran Joins EnGenius' Ranks The telecom game, folks, just got a little more interesting with EnGenius Technologies strapping itself in for a channel-first journey across the U.S. and Canada. They've placed a seasoned player, Rachel Saunders, into the cockpit as Vice President of Sales, North America. Her resume reads like a telecom scout's dream: 17 years in electric...
Continue Reading
An Honest Take: Faith, Growth, and Surrender A player in the world of spiritual growth literature has stepped up again, and it ain't holding back. Chad Tucker, a name perhaps familiar to folks following transformation tales soaked with faith, has released a beefy sequel to his first hit: The Lord in Us: If You Can Love an Enemy, You Can Love Anyone. Well, now he's back...
Continue Reading
A Bold Move to Elevate Roofing Standards In a move that seems to jolt the roofing industry awake, Guaranteed Roof is taking the wraps off its new strategic partnership with LB Capital and EM Exteriors. Think of it as a power trio aiming to redefine what roofing solutions should mean in the Southeast. It’s the kind of news that makes you sit up and ask, why now and why...
Continue Reading
Metriport's Push into the TEFCA Framework Son of a gun, Metriport's making noise in the health data world! They just got the nod as a Candidate QHIN under the Trusted Exchange Framework and Common Agreement, or TEFCA if you're into acronyms. This isn't just some digital high-five; it's a significant stride forward for healthcare data exchange. Now they're smack in the...
Continue Reading
A Surgeon's Story Comes to Henry County Ah, the medical field. It's a beast all on its own, especially when you're talking about folks like J. Hunter Matthews, M.D. making waves in the orthopedic world. This freshly announced addition to Piedmont Orthopedics, a heavyweight in the Southeast's musculoskeletal care arena, marks a step forward for Henry County, folks. We're...
Continue Reading
WareSpace Makes Strategic Moves in Tight Markets In a bold gamble, WareSpace dropped $36.5 million to snag fresh industrial real estate in Miami Gardens, Florida, and South San Francisco, California. These aren't random picks, mind you. They're strategic grabs in markets where finding space ain't easier than winning the lottery. With more than 210 flexible units for small...
Continue Reading
Igniting a Celebration of Appalachian Soul Now here's a sound that hits you right in the gut. Aristotle Jones, known out there as the 'Appalachian Soul Man,' is making a big move. He's laying out the plan to make July the Appalachian Soul Month. This fellow isn't shy about celebrating the deep roots of Appalachian music, dropping his album Appalachian Soul Power and a new...
Continue Reading
Top 5 Most Recently Viewed Articles
Empowering Community Leaders with Essential Resources Community Associations Institute, a renowned authority in the realm of condominium and homeowners associations, has recently unveiled a transformative resource titled Board Member Handbook: A Guide for Community Association Leaders. This handbook is meticulously crafted to bolster the capabilities of volunteer board...
Continue Reading
Understanding the Terran Orbital Class Action Lawsuit Pomerantz LLP has initiated a class action lawsuit against Terran Orbital Corporation (NYSE: LLAP) and its executives. The lawsuit, filed in a Florida district court, aims to represent individuals and entities that acquired Terran's securities within a defined class period, seeking restitution for alleged damages due...
Continue Reading
Recent Developments in Myeloma Treatment Johnson & Johnson has made significant strides recently, demonstrating strong clinical efficacy with an innovative immune-based treatment for multiple myeloma. The combination of Tecvayli (teclistamab) and Darzalex Faspro (daratumumab and hyaluronidase) has showcased remarkable effectiveness in newly diagnosed patients who are...
Continue Reading
OSE Immunotherapeutics Unveils New Treatment Insights OSE Immunotherapeutics, a prominent biotech company, has shared exciting preclinical data regarding its innovative treatment targeting chronic colitis. The focus of this groundbreaking research is the combination of the anti-IL-7 receptor, Lusvertikimab, with an anti-IL-12/23 monoclonal antibody. Presented during an...
Continue Reading
Antibiotics Market Overview Antibiotics are essential medications that play a critical role in modern medicine, addressing various bacterial infections and contributing significantly to public health. The antibiotics market is currently valued at approximately USD 50.8 billion and is projected to surge to USD 72.9 billion by 2032, representing a compound annual growth...
Continue Reading